Krsnaa Diagnostics has scheduled its 16th Annual General Meeting (AGM) for Monday, September 28, 2026, at 11:00 am. The meeting will take place at the company’s registered office in Pune, Maharashtra.

The notice for the AGM and the Annual Report for FY26, including financial statements for the year ended March 31, 2026, will be sent electronically to shareholders with registered email addresses. These documents are also available on the company’s website and the National Securities Depository Limited (NSDL) portal.

Voting Schedule and Procedures

Remote e-voting will commence on Friday, September 25, 2026, at 9:00 am and conclude on Sunday, September 27, 2026, at 5:00 pm. Shareholders holding shares in physical or dematerialized form may cast their votes electronically during this window. The voting module will be disabled by NSDL after the deadline.

Shareholders who acquire shares after the dispatch of the notice but hold them as on the cut-off date of Friday, September 18, 2026, can obtain login credentials by contacting NSDL or the Registrar and Share Transfer Agent, Kfin Technologies Limited.

Corporate Actions and Record Dates

The Register of Members and Share Transfer Books will remain closed from Friday, September 18, 2026, to Monday, September 28, 2026, inclusive. This closure is mandated under Section 91 of the Companies Act, 2013, and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Physical shareholders without registered email IDs must submit their details, including folio numbers and identity proofs, to the RTA via email or through Form ISR-1 available on the company’s investor relations page. Demat holders are advised to update their email addresses with their depository participants.

Krsnaa Diagnostics issued a corrigendum to its postal ballot notice on August 28, 2026, following requests from the National Stock Exchange of India Limited for additional clarity. The company is seeking shareholder approval for a preferential issue of share warrants.

The original notice was dispatched on August 18, 2026, in compliance with the Companies Act, 2013, and SEBI regulations. The NSE directed the amendment via letters dated August 24, 2026, requiring specific disclosures regarding the proposed transaction.

Shareholding Changes

The corrigendum details the impact of the preferential issue on the promoter group's stake. The promoters intend to subscribe to 16,21,000 equity shares post-conversion of warrants. This acquisition will increase their aggregate holding from 27.11% to 29.70% on a fully diluted basis.

The increase falls within the limits permitted under Regulation 3(2) of the SEBI SAST Regulations for creeping acquisitions. Consequently, no open offer obligation is triggered under Regulation 10.

Allottee Details

Two entities within the promoter group have confirmed their intention to subscribe:

• Mr. Rajendra Khivraj Mutha: 75,000 warrants
• Krsna Diagnostics (Mumbai) Private Limited: 15,46,000 warrants

No other directors, key managerial personnel, or senior management members intend to participate in the issue. The transaction will not result in any change in control or composition of the Board of Directors.

Voting Process

Remote e-voting commenced on August 19, 2026, and concludes on September 17, 2026, at 5:00 pm. Shareholders who voted prior to receiving this corrigendum may modify their votes by emailing the scrutinizer at csdineshbirla@gmail.com with a copy to cs@krsnaa.in before the deadline.

What the Numbers Show

The preferential issue is entirely internal, with all new capital coming from existing promoter entities. Mr. Rajendra Mutha’s direct holding decreases slightly from 24.75% to 23.11%, while his indirect holding through Krsna Diagnostics (Mumbai) Private Limited rises significantly from 2.36% to 6.59%. This shift consolidates promoter control without diluting public or institutional investors, whose stakes remain unchanged in absolute numbers but decrease proportionally due to the expanded share base.